MedPath

A Trial of Supplemental CO2 Versus Room Air in Percutaneous Endoscopic Gastrostomy

Not Applicable
Completed
Conditions
Pneumoperitoneum
Registration Number
NCT02619656
Lead Sponsor
University of Utah
Brief Summary

The investigators hypothesize that using carbon dioxide for PEG placement versus using room air will decrease post-procedure pneumoperitoneum as well as improve post-procedure bloating/pain, and waist circumference.

Detailed Description

Background and study aims: Pneumoperitoneum following PEG placement has been reported in up to 60% of cases, and while usually benign and self-limited, it can lead to evaluation for suspected perforation. This study was designed to determine whether using CO2 compared to ambient air for insufflation during PEG reduces post-procedure pneumoperitoneum.

Patients and Methods: Prospective, double blind, randomized trial of 35 consecutive patients undergoing PEG at a single academic medical center. Patients were randomized to insufflation with CO2 or ambient air. Primary outcome was pneumoperitoneum determined by left-lateral decubitus abdominal x-rays 30 min after PEG placement. Secondary endpoints included abdominal distention, pain, and bloating.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
35
Inclusion Criteria
  • Participants must be over the age of 18 and need a percutaneous endoscopic gastrostomy
Exclusion Criteria
  • None

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Post-procedure pneumoperitoneumleft-lateral decubitus abdominal x-rays 30 min after PEG placement.

Frequency of post pneumoperitoneum determined by left-lateral decubitus abdominal x-rays 30 min after PEG placement.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Utah SOM

🇺🇸

Salt Lake City, Utah, United States

University of Utah SOM
🇺🇸Salt Lake City, Utah, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.